KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,487 | -39.5% | 310,065 | -19.2% | 0.07% | -42.3% |
| Q2 2023 | $687,088 | +54.5% | 383,848 | +193.4% | 0.12% | +30.9% |
| Q4 2022 | $444,778 | +101.3% | 130,817 | +222.7% | 0.09% | +70.9% |
| Q3 2022 | $221,000 | -5.2% | 40,541 | -21.4% | 0.06% | -42.1% |
| Q2 2022 | $233,000 | +119.8% | 51,606 | +257.7% | 0.10% | +106.5% |
| Q1 2022 | $106,000 | +26.2% | 14,429 | +10.6% | 0.05% | -4.2% |
| Q4 2021 | $84,000 | -11.6% | 13,051 | -19.8% | 0.05% | +50.0% |
| Q3 2021 | $95,000 | – | 16,272 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |